WEST CHESTER, Ohio, Oct., 6–(HSMN NewsFeed)–AtriCure, Inc. (Nasdaq: ATRC ), a medical device company and a leader in cardiac surgical ablation systems, today announced CE Mark approval for its AtriClip Gillinov-Cosgrove Left Atrial Appendage Exclusion Sy…
Devices, Cardiology, Regulatory
AtriCure, AtriClip

If you are a sales professional or want to become one, or if you are looking for a new sales job, you will face one of the toughest interview processes of any job seeker.
0 Comments on “AtriCure Announces European Approval for its AtriClip System”
Leave a Comment